Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...

Stryker has entered a definitive agreement to acquire complete issued and outstanding shares of Inari Medical’s common stock for $80 per share in cash, which equates to a total equity value of ...

Stryker (SYK) agreed to acquire medical technology maker Inari Medical (NARI) in an all-cash deal worth roughly $4.9 billion as the company looks to boost its neurovascular and endovascular segments.

Stryker plans to acquire Inari Medical in a deal valued at $4.9 billion and designed to strength its position in the peripheral vascular market. The deal, announced Monday and approved by both ...

As it coincides, Stryker announced another big deal already in the year, starting 2025 with a nearly $5 billion purchase of Inari Medical, Inc. (NARI). This seems like a typical sound Stryker deal ...

Stryker acquires Inari Medical for $80/share, valuing the deal at $4.9 billion, expanding its venous thromboembolism portfolio. Mechanical thrombectomy for VTE is a $6 billion US market ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Now that the year is underway and a new presidential administration is in place in Washington, let’s consider the environment ...

Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical ...

Inari Medical Inc., one of Orange County’s fastest-growing medical device makers, is being acquired for $4.9 billion by global medical technology company Stryker Corp. Stryker on Jan. 6 announced an ...

Stryker, one of the world’s largest medtech companies, announced on January 28 that it would be selling its Spinal Implants business to ...